DICLOFENAC POTASSIUM
| Brand name | ZIPSOR |
|---|---|
| Active ingredient | DICLOFENAC POTASSIUM |
| Strength | 25MG |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | June 2009 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 7884095 | February 2029 | use U-1111 |
| 8110606 | February 2029 | use U-980 |
| 7662858 | February 2029 | use U-1035 |
| 7939518 | February 2029 | use U-980 |
| 8623920 | February 2029 | use U-1482 |
| 9561200 | February 2029 | use U-1482 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.